Development · 10 Oct 2026
3 publishers have reported this development. Each act of reporting is below, cited.
The Government has approved a cap on trade margins charged in the supply and sale of non-scheduled anti-cancer drugs at 30 percent of the Maximum Retail Price.
The government has approved a proposal to cap trade margins on identified non-scheduled anti-cancer medicines at 30% of the maximum retail price.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.